Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


7th Annual Proteins & Antibodies Congress

03 Apr 2014 - 04 Apr 2014 - London, UK



Bookmark and Share


The 7th Annual Proteins & Antibodies Congress is the single most senior-level focused event in Europe, dedicated to key technological and scientific advances in the proteins industry. As the only conference to bring together all the experts in the biopharmaceutical industry, this exciting meeting is a must attend for anyone working in the field of proteins and antibodies. 

The Proteins & Antibodies Congress covers the key challenges and critical opportunities in protein purification, expression and characterisation, antibody discovery, development, engineering, bispecific antibodies and antibody drug conjugates. Gain insight and discover innovative solutions to the challenges of biotherapeutics optimisation, scaffold development and immunogenicity testing

Over  two days, the event will attract over 220 senior decision makers from Europe and the US with a comprehensive conference program featuring four separate streams, keynote addresses, case study presentations and interactive panel discussions given by over 45 expert speakers from leading pharmaceutical, biotech, academic and research institutes. 

On Day One, the congress will address the most pressing challenges in protein purification, expression and characterisation through a series of cutting-edge conference presentations. Our antibody experts debate the future of bispecific antibodies, novel screening technologies, and next generation antibody discovery techniques. 

On Day Two, learn more about current developments in selecting the optimal biotherapeutic candidate, extending half life and overcoming immunogenicity and aggregation challenges. Do not miss out on the chance to discover innovative solutions to increasing the clinical success rate of engineered antibodies and targeting difficult receptors.  


Contact Danielle Dalby to download the agenda and for attendance information on d.dalby@oxfordgloabl.co.uk or call +44 (0)1865 248455




Further information
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
How To Keep Your Rice Arsenic-Free
Researchers at Queen’s University Belfast have made a breakthrough in discovering how to lower worrying levels of arsenic in rice that is eaten all over the world.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Computer Model Could Explain how Simple Molecules Took First Step Toward Life
Two Brookhaven researchers developed theoretical model to explain the origins of self-replicating molecules.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!